OFIX
Orthofix Medical Inc.
9.35
2 x 6.79
2 x 11.92
bid
ask
+
0.21
2.30%
2 @ 04:00 PM
9.35 +0.00 (0.00%)
| Ytd | -38.32% | |
| 1y | -16.37% |
9.24
day range
9.61
8.85
52 week range
16.99
| Open | 9.24 | Prev Close | 9.14 | Low | 9.24 | High | 9.61 | Mkt Cap | 377.94M |
| Vol | 421.97K | Avg Vol | 391.52K | EPS | -1.50 | P/E | N/A | Forward P/E | -1733.00 |
| Beta | 1.05 | Short Ratio | 3.89 | Inst. Own | 92.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 10.67 | 200-d Avg | 13.26 | 1yr Est | 24.40 |
| Income Statement | |||
| Total Revenue | 196.71M | ||
| Revenues (USD) | 196.71M | ||
| Cost of Revenue | 57.16M | ||
| Gross Profit | 139.55M | ||
| Operating Expenses | 153.98M | ||
| Research and Development Expense | 15.32M | ||
| Selling, General and Administrative Expense | 134.91M | ||
| Operating Income | -14.44M | ||
| Interest Expense | 5.66M | ||
| Income Tax Expense | 74.00K | ||
| Net Income | -20.91M | ||
| Net Income Common Stock | -20.91M | ||
| Net Income Common Stock (USD) | -20.91M | ||
| Consolidated Income | -20.91M | ||
| Earnings per Basic Share | -0.52 | ||
| Earnings per Basic Share (USD) | -0.52 | ||
| Earnings per Diluted Share | -0.52 | ||
| Earning Before Interest & Taxes (EBIT) | -15.17M | ||
| Earning Before Interest & Taxes (USD) | -15.17M | ||
| Weighted Average Shares | 40.45M | ||
| Weighted Average Shares Diluted | 40.45M | ||
| Balance Sheet | |||
| Cash and Equivalents | 120.87M | ||
| Cash and Equivalents (USD) | 120.87M | ||
| Trade and Non-Trade Receivables | 137.78M | ||
| Current Assets | 461.52M | ||
| Property, Plant & Equipment Net | 125.33M | ||
| Total Assets | 886.60M | ||
| Debt Current | 115.00K | ||
| Total Debt | 234.39M | ||
| Current Liabilities | 161.03M | ||
| Debt Non-Current | 234.27M | ||
| Total Liabilities | 451.42M | ||
| Accumulated Retained Earnings (Deficit) | -389.24M | ||
| Accumulated Other Comprehensive Income | 142.00K | ||
| Shareholders Equity | 435.19M | ||
| Shareholders Equity (USD) | 435.19M | ||
| Assets Non-Current | 425.08M | ||
| Total Debt (USD) | 234.39M | ||
| Goodwill and Intangible Assets | 264.27M | ||
| Inventory | 177.82M | ||
| Liabilities Non-Current | 290.38M | ||
| Trade and Non-Trade Payables | 54.69M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 13.49M | ||
| Net Cash Flow from Financing | 63.97M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 35.76M | ||
| Capital Expenditure | -10.66M | ||
| Issuance (Repayment) of Debt Securities | 63.97M | ||
| Net Cash Flow from Investing | -10.51M | ||
| Net Cash Flow from Operations | -17.61M | ||
| Effect of Exchange Rate Changes on Cash | -90.00K | ||
| Share Based Compensation | 6.53M | ||